Detalhe da pesquisa
1.
Phase 1 dose escalation trial of TAS-102 (trifluridine/tipiracil) and temozolomide in the treatment of advanced neuroendocrine tumors.
Invest New Drugs
; 38(5): 1520-1525, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253554
2.
Metastatic Bulk Independently Predicts Outcomes for EGFR Precision Targeting in Colorectal Cancer.
J Natl Compr Canc Netw
; 16(12): 1442-1450, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545991
3.
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 317(23): 2392-2401, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632865
4.
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors.
Oncologist
; 21(7): 785-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27261467
5.
A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer.
Invest New Drugs
; 34(2): 168-75, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26666244
6.
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.
Invest New Drugs
; 33(1): 169-76, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25318436
7.
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
Invest New Drugs
; 31(4): 943-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23263993
8.
Pregnancy Screening in Patients With Cancer.
J Natl Compr Canc Netw
; 16(1): 99-103, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29295884
9.
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
Oncologist
; 16(4): 452-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21393344
10.
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer.
Int J Radiat Oncol Biol Phys
; 109(2): 458-463, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32942002
11.
Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis.
J Gastrointest Oncol
; 12(4): 1454-1469, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34532102
12.
National Comprehensive Cancer Network Infusion Efficiency Workgroup Study: Optimizing Patient Flow in Infusion Centers.
J Oncol Pract
; 15(5): e458-e466, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30964732
13.
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors.
Clin Cancer Res
; 13(12): 3623-9, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17510207
14.
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study.
Clin Cancer Res
; 13(12): 3660-6, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17575231
15.
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.
Clin Cancer Res
; 13(16): 4832-9, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17699862
16.
Multidisciplinary Optimization of Oral Chemotherapy Delivery at the University of Wisconsin Carbone Cancer Center.
J Oncol Pract
; 12(10): e912-e923, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27858570
17.
Precision medicine in colorectal cancer: the molecular profile alters treatment strategies.
Ther Adv Med Oncol
; 7(5): 252-62, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26327923
18.
A phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer.
Cancer Chemother Pharmacol
; 76(2): 317-23, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26068189
19.
Capecitabine-related neurotoxicity presenting as trismus.
Clin Colorectal Cancer
; 3(2): 121-3, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12952569
20.
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study.
Clin Cancer Res
; 19(13): 3631-9, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23653147